Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.

To define the metabolic defect in Tangier disease, we studied the kinetics of [125I]-high-density lipoprotein apolipoproteins (apolipoproteins A-I and A-II) in 11 normal subjects, two obligate heterozygotes, and two homozygotes. Mean synthesis of apolipoproteins A-1 and A-11 was 8.24 mg per kilogram per day in the normal group, 7.94 in heterozygotes and 3.66 in homozygotes. The mean plasma-residence time for both apolipoproteins was 5.21 days in the normal subjects, 3.41 days in heterozygotes, and 0.52 days in homozygotes. In normal subjects and heterozygotes the apolipoproteins were catabolized at similar rates, whereas in homozygotes apolipoprotein A-I was catabolized at a much greater fractional rate than apolipoprotein A-II. These findings indicate that the deficiency of these apolipoproteins in Tangier disease is largely due to rapid and altered catabolism.

[1]  E. Schaefer,et al.  Lipoprotein apoprotein metabolism. , 1978, Journal of lipid research.

[2]  D. Fredrickson,et al.  Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease. , 1978, Metabolism: clinical and experimental.

[3]  H. Brewer,et al.  Human chylomicron apolipoprotein metabolism. , 1978, Biochemical and biophysical research communications.

[4]  S. Formisano,et al.  Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex. , 1978, The Journal of biological chemistry.

[5]  D. Fredrickson,et al.  Properties of the plasma very low and low density lipoproteins in Tangier disease. , 1978, The Journal of clinical investigation.

[6]  S. Eisenberg,et al.  Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects. , 1978, Journal of lipid research.

[7]  G. Assmann,et al.  Characterization of high density lipoproteins in patients heterozygous for Tangier disease. , 1977, The Journal of clinical investigation.

[8]  C. Blum,et al.  High density lipoprotein metabolism in man. , 1977, The Journal of clinical investigation.

[9]  G. Assmann,et al.  Isolation and Characterization of an Abnormal High Density Lipoprotein in Tangier Disease , 1977 .

[10]  D. Thelle,et al.  THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.

[11]  S B Hulley,et al.  HDL Cholesterol and Other Lipids in Coronary Heart Disease: The Cooperative Lipoprotein Phenotyping Study , 1977, Circulation.

[12]  G. Assmann,et al.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. , 1977, The Journal of clinical investigation.

[13]  H. Brewer,et al.  The plasma lipoproteins. , 1977, Advances in protein chemistry.

[14]  P. Alaupovic,et al.  Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays. , 1976, Clinical chemistry.

[15]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[16]  S. Eisenberg,et al.  Radioimmunoassay of human high density lipoprotein apo-protein A-1. , 1975, Biochimica et biophysica acta.

[17]  V. Ferrans,et al.  The pathology of Tangier disease. A light and electron microscopic study. , 1975, The American journal of pathology.

[18]  A. Gotto,et al.  Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein. , 1972, The Journal of clinical investigation.

[19]  P. Nestel,et al.  Tangier disease. Report of a case and studies of lipid metabolism. , 1972, The New England journal of medicine.

[20]  Denis Williams,et al.  FAMILIAL α-LIPOPROTEIN DEFICIENCY (TANGIER DISEASE) WITH NEUROLOGICAL ABNORMALITIES , 1967 .

[21]  P. Bergner Tracer dynamics and the determination of pool-sizes and turnover factors in metabolic systems. , 1964, Journal of theoretical biology.

[22]  D. Fredrickson THE INHERITANCE OF HIGH DENSITY LIPOPROTEIN DEFICIENCY (TANGIER DISEASE). , 1964, The Journal of clinical investigation.

[23]  L. Avioli,et al.  Tangier Disease: Combined Clinical Staff Conference at the National Institutes of Health , 1961 .

[24]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.